Rübben Albert, Kempf Werner, Kadin Marshall E, Zimmermann Dieter R, Burg Günter
Department of Dermatology, UniversitätsSpital Zürich, Zürich, Switzerland.
Exp Dermatol. 2004 Aug;13(8):472-83. doi: 10.1111/j.0906-6705.2004.00176.x.
Molecular analysis of solid malignant tumors has suggested multilineage progression of genetically unstable subclones during early stages of tumorigenesis as a common mechanism of tumor cell evolution. We have investigated whether multilineage progression is a feature of cutaneous T-cell lymphoma (CTCL). To identify individual tumor cell subclones, we determined the pattern of mutations within microsatellite DNA obtained from multiple histomorphologically confined tumor cell nests of mycosis fungoides (MF) and lymphomatoid papulosis (LyP) lesions. Tumor cells were isolated by laser microdissection, and allelotypes were determined at microsatellite markers D6S260, D9S162, D9S171, D10S215, TP53.PCR15, and D18S65. Nine cases of MF and one patient with anaplastic large cell lymphoma (ALCL) originating from LyP were analyzed at 277 different microdissected areas obtained from 31 individual lesions. Three specimens of cutaneous lichen planus microdissected at 26 areas served as the control tissue. Microsatellite instability in microdissected tissue [MSI(md-tissue)] was detected in tumor tissues of all CTCL patients. One hundred and fifty-seven of 469 analyzed polymerase chain reaction (PCR) amplifications contained mutated microsatellite alleles (34%). In lichen planus, MSI(md-tissue) was seen in only four of 76 PCR products (5%) (P < 0.0001). The distribution of allelotypes in tumor cells from different disease stages was consistent with multilineage progression in five MF cases, as well as in the LyP/ALCL patient. Our results suggest that CTCL may evolve by multilineage progression and that tumor subclones in MF can be detected in early disease stages by mutation analysis of microsatellite DNA obtained from multiple microdissected areas.
实体恶性肿瘤的分子分析表明,在肿瘤发生的早期阶段,基因不稳定的亚克隆的多谱系进展是肿瘤细胞进化的常见机制。我们研究了多谱系进展是否是皮肤T细胞淋巴瘤(CTCL)的一个特征。为了识别单个肿瘤细胞亚克隆,我们确定了从蕈样肉芽肿(MF)和淋巴瘤样丘疹病(LyP)病变的多个组织形态学局限的肿瘤细胞巢中获得的微卫星DNA内的突变模式。通过激光显微切割分离肿瘤细胞,并在微卫星标记D6S260、D9S162、D9S171、D10S215、TP53.PCR15和D18S65处确定等位基因型。对9例MF病例和1例起源于LyP的间变性大细胞淋巴瘤(ALCL)患者的31个个体病变的277个不同显微切割区域进行了分析。在26个区域进行显微切割的3份皮肤扁平苔藓标本用作对照组织。在所有CTCL患者的肿瘤组织中均检测到显微切割组织中的微卫星不稳定性[MSI(md组织)]。在469次分析的聚合酶链反应(PCR)扩增中,有157次包含突变的微卫星等位基因(34%)。在扁平苔藓中,仅在76个PCR产物中的4个(5%)中观察到MSI(md组织)(P<0.0001)。来自不同疾病阶段的肿瘤细胞中等位基因型的分布与5例MF病例以及LyP/ALCL患者中的多谱系进展一致。我们的结果表明,CTCL可能通过多谱系进展而演变,并且通过对从多个显微切割区域获得的微卫星DNA进行突变分析,可以在MF的早期疾病阶段检测到肿瘤亚克隆。